The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors
Abstract
OBJECTIVE: Cleared blood glucose monitors (BGMs) for personal use may not always deliver levels of accuracy currently specified by international and U.S. regulatory bodies. This study’s objective was to assess the accuracy of 18 such systems cleared by the U.S. Food and Drug Administration representing approximately 90% of commercially available systems used from 2013 to 2015. RESEARCH DESIGN AND METHODS: A total of 1,035 subjects were recruited to have a capillary blood glucose (BG) level measured on six different systems and a reference capillary sample prepared for plasma testing at a reference laboratory. Products were obtained from consumer outlets and tested in three triple-blinded studies. Each of the three participating clinical sites tested a different set of six systems for each of the three studies in a round-robin. In each study, on average, a BGM was tested on 115 subjects. A compliant BG result was defined as within 15% of a reference plasma value (for BG ≥100 mg/dL [5.55 mmol/L]) or within 15 mg/dL (0.83 mmol/L) (for BG <100 mg/dL [5.55 mmol/L]). The proportion of compliant readings in each study was compared against a predetermined accuracy standard similar to, but more lenient than, current regulatory standards. Other metrics of accuracy included the overall compliance proportion; the proportion of extreme outlier readings differing from the reference value by >20%; modified Bland-Altman analysis including average bias, coefficient of variation, and 95% limits of agreement; and proportion of readings with no clinical risk as determined by the Surveillance Error Grid. RESULTS: The different accuracy metrics produced almost identical BGM rankings. Six of the 18 systems met the predetermined accuracy standard in all three studies, 5 systems met it in two studies, and 3 met it in one study. Four BGMs did not meet the accuracy standard in any of the three studies. CONCLUSIONS: Cleared BGMs do not always meet the level of analytical accuracy currently required for regulatory clearance. This information could assist patients, professionals, and payers in choosing products and regulators in evaluating postclearance performance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, comparability of the study by Klonoff et al and our study is limited because Klonoff included BGMS which were cleared by the Food and Drug Administration (FDA) when accuracy criteria were milder than current criteria and applied a non-official accuracy standard which is more lenient than ISO and FDA specifications.29”
From System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015 (2020) · cites this paper as [29]
In the citing paper
“In another accuracy study with the 18 best-selling BGMS in the USA by Klonoff et al,29 12 out of 18 tested BGMS were not meeting accuracy requirements similar to ISO 15197.”
From System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015 (2020) · cites this paper as [29]
In the citing paper
“Most meters meet the accuracy standards established by the International Organization for Standardization”
In the citing paper
“In one analysis, 6 of the top 18 best-selling glucose meters met the accuracy standard (19).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [19]
In the citing paper
“Although measurement quality can come close to or equal that of the glucose monitoring systems used by healthcare professionals, several available SMBG systems still do not meet internationally accepted accuracy standards, such as the International Organization for Standardization 15197 standard.”
From Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus (2022) · cites this paper as [24]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
International Organization for Standardization
(2015) · Encyclopedia of Astrobiology · doi:10.1007/978-3-662-44185-5_100574 · Cited by 6,716
Glucose Meters: A Review of Technical Challenges to Obtaining Accurate Results
Tonyushkina, K., & Nichols, J. H. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300446 · Cited by 406
Self-citationKlonoff, D. C., Lias, C., Vigersky, R., Clarke, W., Parkes, J. L., Sacks, D. B., Kirkman, M. S., Kovatchev, B., Panel, T. E. G., Aurand, L., et al. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814539589 · Cited by 174
Self-citationComparative accuracy of 17 point-of-care glucose meters
Ekhlaspour, L., Mondesir, D., Lautsch, N., Balliro, C., Hillard, M., Magyar, K., Radocchia, L. G., Esmaeili, A., Sinha, M., & Russell, S. J. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816672237 · Cited by 127 · cited 1×
“A BGM was considered to have met the standard unless the proportion compliant was in the “clear rejection zone” (7).”
MethodBreton, M. D., & Kovatchev, B. P. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400309 · Cited by 103
Self-citationHeinemann, L. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0076 · Cited by 69
Performance of Cleared Blood Glucose Monitors
Klonoff, D. C., & Prahalad, P. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815584797 · Cited by 59
Self-citationComputing the Surveillance Error Grid Analysis: Procedure and Examples
Kovatchev, B. P., WAKEMAN, C. A., Breton, M. D., Kost, G. J., Louie, R. F., Tran, N. K., & Klonoff, D. C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814539590 · Cited by 51
Self-citationSchmid, C., Haug, C., Heinemann, L., & Freckmann, G. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0047 · Cited by 34
Blood Glucose Pattern Management in Diabetes: Creating Order from Disorder
Choudhary, P., Genovese, S., & Reach, G. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700618 · Cited by 30
Research works printed but not linked: 1
- Fein, 2015, 2014-15 Economic Report on Retail, Mail, and Specialty Pharmacies
Cited by
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05568-3 · Cited by 378
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
Metadata
- Authors
- Klonoff, D. C., Parkes, J. L., Kovatchev, B. P., Kerr, D., Bevier, W. C., Brazg, R. L., Christiansen, M., Bailey, T. S., Nichols, J. H., & Kohn, M. A.
- Affiliations
- Mills-Peninsula Medical Center, Diabetes Research Institute, San Mateo, CA
- Joan Lee Parkes Consulting, Inc., Bristol, IN
- University of Virginia (US)
- Sansum Diabetes Research Institute (US)
- Rainier Clinical Research Center (US)
- Diablo Clinical Research (US)
- AMCR Institute (US)
- Vanderbilt University (US)
- University of California, San Francisco (US)
- Corresponding author
- Klonoff, David C.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-06-13
- Volume
- 41
- Issue
- 8
- Pages
- 1681-1688
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2808448482
- Cited by
- 144
- References
- 12
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 14 · 2023: 12 · 2022: 15 · 2021: 24 · 2020: 26 · 2019: 25 · 2018: 6
- FWCI
- 16.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Abbott Diabetes Care
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- blood glucose meters, point-of-care glucose testing, accuracy, regulatory approval, capillary blood glucose, Bland-Altman analysis, consumer product evaluation, diabetes self-monitoring
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Blood Glucose, Commerce, Diabetes Mellitus, Double-Blind Method, Equipment and Supplies, Female, Hematocrit, Humans, Male, Middle Aged, Patient Compliance, Prediabetic State, Reference Values, United States, United States Food and Drug Administration, Blood Glucose Self-Monitoring, Reproducibility of Results, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors. https://app.cochat.ai/papers/10.2337/dc17-1960
- The paper
- Klonoff, D. C., Parkes, J. L., Kovatchev, B. P., Kerr, D., Bevier, W. C., Brazg, R. L., Christiansen, M., Bailey, T. S., Nichols, J. H., & Kohn, M. A. (2018). Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors. Diabetes Care. https://doi.org/10.2337/dc17-1960
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.